VOR
$19.03+5.49%
Vor Biopharma Inc.Stock · HealthcareRussell 2000 · 0.02% of IWMNasdaq Composite · 0.002% of ONEQUS Stock Market · 0.001% of VTIRussell 3000 · 0.001% of IWV
VOR financial statements
The full income statement, balance sheet, and cash-flow statement for Vor Biopharma Inc. (VOR), plus valuation ratios — straight from SEC filings. Switch between annual, quarterly, and trailing-twelve-month figures, pick how far back to look, and flip the time order. Every line has a trend sparkline.
Shares outstanding (point-in-time)
2025-09 10.4M2025-12 38.7M2026-03 54.2M2026-06 59.2M+468.3% over 3 periods
SEC-filed end-of-period counts (cover pages and balance sheets, split-adjusted) — the series realized buyback yield is computed from. The weighted-average share lines in the statements below lag these by design: an average over the year sits near the midpoint of an ongoing buyback.
PeriodRangeOrderChangeFiguresAs-reported fiscal years.
| Line item | Trend | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|---|
| Income Statement | as ofDec 31 ’25 | as ofDec 31 ’24 | as ofDec 31 ’23 | as ofDec 31 ’22 | as ofDec 31 ’21 | |
| 372M+206.7% | 121M-3.8% | 126M+34.9% | 93.4M+35.4% | 69.0M+59.2% | ||
| Research & development | 322M+244.6% | 93.3M-1.1% | 94.3M+46.1% | 64.5M+35.8% | 47.5M+50.3% | |
| Selling, general & administrative | 50.1M+79.8% | 27.9M-12.1% | 31.7M+9.9% | 28.9M+34.3% | 21.5M+82.9% | |
| General & administrative | 50.1M+79.8% | 27.9M-12.1% | 31.7M+9.9% | 28.9M+34.3% | 21.5M+82.9% | |
| Restructuring | 29.7M | — | — | — | — | |
| Operating income | -372M-206.7% | -121M+3.8% | -126M-34.9% | -93.4M-35.4% | -69.0M-59.2% | |
| Interest & investment income | 5.87M+37.4% | 4.27M-47.7% | 8.17M+517.3% | 1.32M+1012.6% | 119K+310.3% | |
| Other non-operating income | -324M-7694.0% | 4.27M-47.7% | 8.17M+517.3% | 1.32M+1012.6% | 119K+310.3% | |
| -696M-495.3% | -117M+0.8% | -118M-28.0% | -92.1M-33.7% | -68.9M-59.0% | ||
| Net income to common | — | — | -118M-28.0% | -92.1M-31.3% | -70.1M-42.4% | |
| -$70.50-107.2% | -$34.03-1844.6% | -$1.75+24.9% | -$2.33-11.0% | -$2.10 | ||
| EPS (basic) | -$70.50-107.2% | -$34.03-1844.6% | -$1.75+24.9% | -$2.33-11.0% | -$2.10 | |
| Weighted-avg shares (basic) | 9.87M+187.3% | 3.44M-94.9% | 67.2M+69.9% | 39.6M+18.3% | 33.4M | |
| Weighted-avg shares (diluted) | 9.87M+187.3% | 3.44M-94.9% | 67.2M+69.9% | 39.6M+18.3% | 33.4M | |
| Balance Sheet | as ofDec 31 ’25 | as ofDec 31 ’24 | as ofDec 31 ’23 | as ofDec 31 ’22 | as ofDec 31 ’21 | |
| 458M+374.7% | 96.5M-31.5% | 141M-40.6% | 237M+10.5% | 214M+336.6% | ||
| Cash & equivalents | 396M+383.8% | 81.9M+161.3% | 31.4M-45.7% | 57.7M-51.8% | 120M+146.8% | |
| Short-term investments | 58.7M+488.6% | 9.98M-90.6% | 106M-38.7% | 173M+96.8% | 87.7M | |
| Cash & short-term investments | 455M+395.3% | 91.9M | — | — | — | |
| Prepaid expenses | 1.15M-72.6% | 4.20M+33.2% | 3.15M-27.8% | 4.37M-9.7% | 4.84M+935.5% | |
| Other current assets | 1.75M+359.2% | 380K-20.0% | 475K-79.7% | 2.34M+11.6% | 2.09M+1994.0% | |
| 464M+224.8% | 143M-27.9% | 198M-33.8% | 299M+23.4% | 243M+219.6% | ||
| Property, plant & equipment | 533K-91.9% | 6.58M-34.5% | 10.1M-20.5% | 12.6M+84.4% | 6.85M+44.9% | |
| Operating lease right-of-use | 2.94M-91.6% | 35.0M-12.6% | 40.0M-9.9% | 44.4M+183.6% | 15.7M-8.5% | |
| Other non-current assets | 2.38M+0.0% | 2.38M-50.5% | 4.81M+64.5% | 2.92M-10.1% | 3.25M-4.2% | |
| 25.2M+35.2% | 18.6M+19.5% | 15.6M+18.7% | 13.1M+29.2% | 10.2M-0.5% | ||
| Accounts payable | 5.13M+240.7% | 1.50M+84.7% | 815K-54.0% | 1.77M+14.7% | 1.54M-34.6% | |
| Accrued liabilities | 19.8M+53.3% | 12.9M+18.5% | 10.9M+37.9% | 7.89M+24.5% | 6.33M+1.2% | |
| Current lease liability | 280K-93.4% | 4.21M+10.1% | 3.83M+17.1% | 3.27M+77.9% | 1.84M+113.1% | |
| Other current liabilities | — | 0.00-100.0% | 50.0K-73.1% | 186K-57.1% | 434K-40.0% | |
| 628M+1259.5% | 46.2M-2.5% | 47.4M-2.8% | 48.8M+85.2% | 26.3M-4.7% | ||
| Non-current lease liability | 2.72M-90.2% | 27.6M-13.2% | 31.8M-10.7% | 35.6M+120.4% | 16.2M-7.2% | |
| Operating lease liability (total) | 3.00M-90.6% | 31.8M-10.7% | 35.7M-8.4% | 38.9M+116.0% | 18.0M-1.5% | |
| -164M-270.0% | 96.7M-35.9% | 151M-39.9% | 251M+15.9% | 216M+466.1% | ||
| Common stock | 18.0K+38.5% | 13.0K+85.7% | 7.00K+0.0% | 7.00K+75.0% | 4.00K+300.0% | |
| Additional paid-in capital | 989M+78.6% | 554M+12.8% | 491M+3.7% | 474M+36.7% | 346M+15951.1% | |
| Retained earnings | -1.15B-152.3% | -457M-34.4% | -340M-53.0% | -222M-70.8% | -130M-112.5% | |
| Accumulated other comprehensive income | 41.0K+86.4% | 22.0K+128.6% | -77.0K+90.0% | -770K | — | |
| Total liabilities & equity | 464M+224.8% | 143M-27.9% | 198M-33.8% | 299M+23.4% | 243M+219.6% | |
| Common shares issued | 38.7M+520.6% | 6.24M-90.8% | 67.9M+2.8% | 66.1M+76.8% | 37.4M+4084.3% | |
| Common shares outstanding | 38.7M+520.6% | 6.24M-90.8% | 67.9M+2.9% | 66.0M+77.5% | 37.2M+7260.3% | |
| Shares outstanding (cover) | 48.8M-60.9% | 125M+83.2% | 68.2M+2.7% | 66.4M+77.1% | 37.5M | |
| Cash Flow | as ofDec 31 ’25 | as ofDec 31 ’24 | as ofDec 31 ’23 | as ofDec 31 ’22 | as ofDec 31 ’21 | |
| -143M-43.2% | -99.7M+0.6% | -100M-17.8% | -85.1M-23.1% | -69.1M-90.5% | ||
| Depreciation & amortization | 2.89M-18.2% | 3.53M+1.0% | 3.49M+38.3% | 2.52M+76.1% | 1.43M+137.0% | |
| Share-based compensation | 18.9M+92.1% | 9.85M-26.3% | 13.4M+24.9% | 10.7M+147.9% | 4.32M+221.5% | |
| Other operating activities | — | — | — | -12.0K-106.9% | 174K | |
| -48.8M-150.4% | 96.9M+36.4% | 71.0M+175.5% | -94.1M-2.7% | -91.7M-2102.6% | ||
| Capital expenditure | 941K+310.9% | 229K-78.6% | 1.07M-87.4% | 8.46M+117.3% | 3.89M-6.4% | |
| Free cash flow | -144M-43.8% | -99.9M+1.5% | -101M-8.3% | -93.6M-28.2% | -73.0M-80.6% | |
| Acquisitions | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Purchases of investments | — | — | — | — | 87.8M | |
| Proceeds from sale of PP&E | 799K | 0.00 | — | — | — | |
| 504M+843.6% | 53.4M+1717.3% | 2.94M-97.5% | 117M-49.7% | 233M+182.2% | ||
| Long-term debt issued | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Long-term debt repaid | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Common stock issued | 70.1M+25393.1% | 275K-94.0% | 4.58M+2.9% | 4.45M | 0.00 | |
| Common stock repurchased | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Dividends paid | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net change in cash | 312M+517.3% | 50.6M+292.0% | -26.3M+57.6% | -62.1M-186.1% | 72.1M+71.4% | |
| Valuation Ratios | as ofDec 31 ’25 | as ofDec 31 ’24 | as ofDec 31 ’23 | as ofDec 31 ’22 | as ofDec 31 ’21 | |
| Market cap | 506M | — | — | — | — | |
| Source filing | 10-K | 10-K | 10-K | 10-K | 10-K |
About this data
Source: VOR’s SEC filings (10-K / 10-Q). Annual columns are as-reported fiscal years; quarterly columns are as-reported fiscal quarters (Q4 derived as full-year minus the first three quarters where a company doesn’t file a standalone Q4); TTM (quarterly) rolls the trailing four quarters at every quarter end, TTM (yearly) samples that one year apart; balance-sheet rows show the period-end balance. Valuation ratios are sampled as of each period end. View all VOR filings on SEC EDGAR → Not investment advice.